Neuroscience

Engineered probiotic developed to treat multiple sclerosis

Researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham health care system, have designed a probiotic to suppress autoimmunity in the brain, which occurs when the immune system attacks ...

Medical research

Researchers find a chink in the armor of tuberculosis pathogen

Mycobacterium tuberculosis (Mtb) is the pathogen that causes tuberculosis (TB), the world's deadliest infectious disease. Mtb is so successful and harmful because it can adapt to different conditions inside our bodies, allowing ...

Medications

Common blood thinner may double as cancer therapy

Warfarin, a widely used blood thinner, appears to have potent anti-cancer properties, according to a study by Columbia University researchers. The study, conducted in human cells and in mice, found that warfarin stops tumors ...

Oncology & Cancer

Cellular 'fingerprint' may offer early warning of cancer risk

For nearly every disease, age is a major risk factor, and cancer is no exception. Between the ages of 25 and 65, an individual's risk of developing cancer skyrockets by 4,000%. A new study explores a "fingerprint" in cells ...

page 11 from 40